Focus on Discovery Scales to Support Early-stage Development | Accelerate Oligo-based Drug Discovery
Delivering a broad spectrum of special monomers, diversified oligonucleotides, and custom-tailored solution to oligo-conjugation
Special monomer synthesis — bicyclic nucleic acid, stereo-defined amidite, GalNAc, PMO monomers
Most comprehensive oligonucleotide — siRNA, antisense oligonucleotide (ASO), CpG, aptamer, PMO
Modified oligonucleotide — various bicyclic nucleic acid, 2’-modification, inverted abasic, 5’-VP
Linker-attached oligonucleotide — single-strand and duplex with 3’- or 5’-linker modification, including amino, azido, alkyne, tetrazine, and maleimide, toward antibody conjugation.
Long RNA sequence — up to 100 bp, >90% purity
Oligo-conjugation — siRNA and ASO with 3’- or 5’-conjugation, including GalNAc, Peptide, small molecule, cholesterol, lipid, PEG, fluorescent tag…